Elliptic Laboratories ASA

OB:ELABS Rapport sur les actions

Capitalisation boursière : NOK 400.5m

Elliptic Laboratories Résultats passés

Passé contrôle des critères 0/6

Les bénéfices de Elliptic Laboratories ont diminué à un taux annuel moyen de -26.9%, tandis que le secteur Software a vu ses bénéfices augmenter de en à 13.4% par an. Les revenus ont augmenté de en à un taux moyen de 26.4% par an.

Informations clés

-26.89%

Taux de croissance des bénéfices

-25.32%

Taux de croissance du BPA

Software Croissance de l'industrie52.55%
Taux de croissance des recettes26.37%
Rendement des fonds propres-74.45%
Marge nette-138.16%
Prochaine mise à jour des résultats21 May 2026

Mises à jour récentes des performances passées

Recent updates

Mise à jour de l'analyse Apr 23

ELABS: New Equity Funding And Laptop Agreements Will Support Future Upside

Analysts have maintained their fair value estimate for Elliptic Laboratories at NOK 13.0. Only small adjustments to the discount rate, revenue growth, profit margin and forward P/E have been incorporated into the updated price target framework. What's in the News Elliptic Labs completed multiple follow on equity offerings totaling about NOK 120m, with ordinary shares and other common stock offered at NOK 2.85 per share, including a rights offering and a subsequent direct listing structure (Key Developments).
Mise à jour de l'analyse Apr 09

ELABS: New Equity Funding And Laptop Deployment Will Drive Future Upside

Analysts have kept their NOK 13.0 price target for Elliptic Laboratories unchanged, pointing to stable fair value assumptions supported by a consistent discount rate, revenue growth, profit margin and future P/E inputs. What's in the News Board appoints Ola Sandstad as permanent CEO and Mathias Norderud as permanent CFO, following their interim tenures since late 2025, with both appointments effective immediately (Executive Changes).
Mise à jour de l'analyse Mar 24

ELABS: New Equity Funding And Laptop Wins Will Drive Future Upside

Analysts have kept Elliptic Laboratories' fair value estimate steady at NOK 13.0 per share, with only marginal tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E supporting this unchanged price target. What's in the News The board calls a special shareholders meeting on March 27, 2026 to vote on items including a proposed share capital increase and approval of the meeting notice and agenda (company event notice).
Mise à jour de l'analyse Mar 05

ELABS: Future Laptop And Smartphone Shipments Will Support Upside Potential

Analysts have adjusted their price target for Elliptic Laboratories to reflect updated assumptions on revenue growth of 54.42%, a profit margin of 54.72%, and a future P/E of 8.44. This results in a refreshed fair value estimate of NOK 13.00 per share.
Mise à jour de l'analyse Feb 19

ELABS: New Laptop And Smartphone Deals Will Support Future Upside

Analysts now set their price target for Elliptic Laboratories at NOK 13.00, in line with the prior NOK 13. This reflects updated model inputs around a slightly higher discount rate and unchanged assumptions for revenue growth, profit margin, and future P/E.
Mise à jour de l'analyse Feb 05

ELABS: New Smartphone Licensing Wins Will Support Future Upside Potential

Analysts have maintained their price target for Elliptic Laboratories at €13.0. Their updated assumptions reflect a slightly higher discount rate and a small adjustment to the future P/E multiple, while revenue growth and profit margin expectations remain unchanged. What's in the News Elliptic Labs shipped its AI Virtual Smart Sensor Platform on seven smartphone models in December 2025, including five models from Vivo and two from HONOR, contributing to a total of 65 smartphone models using its technology in 2025 (Key Developments).
Article d'analyse Jan 30

Elliptic Laboratories ASA (OB:ELABS) Stock's 27% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Unfortunately for some shareholders, the Elliptic Laboratories ASA ( OB:ELABS ) share price has dived 27% in the last...
Mise à jour de l'analyse Jan 20

ELABS: Smartphone Platform Wins And New Licensing Pipeline Will Support Upside

Analysts kept their fair value estimate for Elliptic Laboratories steady at €13.00, citing only very small tweaks to their discount rate, revenue growth, profit margin and future P/E assumptions rather than any shift in the core outlook. What's in the News Shipped the AI Virtual Smart Sensor Platform on seven smartphone models in December 2025, including five models from Vivo and two from HONOR, with a total of 65 smartphone models using Elliptic Labs' technology in 2025 (company announcement).
Article d'analyse Jan 09

Returns At Elliptic Laboratories (OB:ELABS) Are On The Way Up

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Mise à jour de l'analyse Jan 06

ELABS: Smartphone Model Wins And New Licensing Will Support Future Upside

Analysts have slightly adjusted their price target for Elliptic Laboratories to reflect a fair value of $13.00. This is supported by unchanged long term assumptions around revenue growth, profit margins, discount rate, and future P/E.
Mise à jour de l'analyse Dec 19

ELABS: Smartphone Deployment Momentum Will Drive Future Upside Despite Leadership Changes

Narrative Update on Elliptic Laboratories Analysts have modestly revised their price target on Elliptic Laboratories to NOK 13.00, reflecting largely unchanged expectations for growth, profitability, and valuation multiples, with only minor model adjustments. What's in the News CEO transition: long-time CEO Laila Danielsen will step down after 12 years, with SVP Product Development and IR Ola Sandstad appointed interim CEO from 6 November 2025 (company announcement) CFO change: CFO Lars Holmøy has resigned after more than four years, with Senior Finance Manager Mathias Norderud named interim CFO effective 24 September 2025, while Holmøy remains to 30 November to support the handover (company announcement) Client momentum: Elliptic Labs shipped its AI Virtual Smart Sensor Platform on nine new smartphone models in September 2025 across HONOR, vivo and Transsion, taking year-to-date launches to 54 models (company announcement) New OEM relationship: the company expanded its reach in October 2025 by debuting on TCL smartphone NxtPaper 60 Ultra, alongside launches with vivo and Xiaomi, lifting year-to-date deployments to 58 models (company announcement) Valuation Changes Fair value: unchanged at NOK 13.0 per share, indicating stable overall valuation assumptions.
Article d'analyse Dec 16

Companies Like Elliptic Laboratories (OB:ELABS) Can Afford To Invest In Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Mise à jour de l'analyse Dec 05

ELABS: Improved Margins And Smartphone Model Wins Will Drive Future Upside

Analysts have lowered their price target for Elliptic Laboratories from NOK 16 to NOK 13, citing tempered revenue growth expectations, which are partly offset by stronger projected profit margins and a more attractive future earnings multiple. What's in the News Long time CEO Laila Danielsen will step down after 12 years at Elliptic Labs, with SVP Product Development and IR Ola Sandstad appointed interim CEO effective 6 November 2025 (company announcement).
Article d'analyse Nov 22

Market Cool On Elliptic Laboratories ASA's (OB:ELABS) Revenues Pushing Shares 30% Lower

To the annoyance of some shareholders, Elliptic Laboratories ASA ( OB:ELABS ) shares are down a considerable 30% in the...
Mise à jour de l'analyse Nov 20

ELABS: Multi-Year PC Licensing Agreements Will Drive Device Expansion Opportunities

Analysts have maintained their price target for Elliptic Laboratories at $16.00. They cite stable expectations for growth and profitability metrics in their latest review.
Mise à jour de l'analyse Nov 06

ELABS: Multi-Year PC Agreements Will Drive Strong Device Expansion Ahead

Narrative Update on Elliptic Laboratories Analysts have maintained their fair value estimate for Elliptic Laboratories at $16.00 per share, citing minor adjustments to the discount rate and valuation inputs while overall expressing consistent conviction in the company's outlook. What's in the News Multiple smartphone launches: Elliptic Labs' AI Virtual Smart Sensor Platform shipped on four new models in October 2025, including a first-time partnership with TCL and continued collaborations with Vivo and Xiaomi.
Mise à jour de l'analyse Oct 23

Analysts Lower Elliptic Labs Price Target Amid Moderated Growth and Evolving Product Partnerships

Analysts have lowered their price target for Elliptic Laboratories from $18.50 to $16.00, citing moderated expectations for revenue growth and profit margins in upcoming periods. What's in the News Elliptic Labs shipped its AI Virtual Smart Sensor Platform on nine smartphone models in September 2025, reaching 54 smartphone models launched for the year to date (Client Announcements).
Article d'analyse May 15

It's Unlikely That Elliptic Laboratories ASA's (OB:ELABS) CEO Will See A Huge Pay Rise This Year

Key Insights Elliptic Laboratories' Annual General Meeting to take place on 21st of May Total pay for CEO Laila...
Article d'analyse May 14

Elliptic Laboratories ASA's (OB:ELABS) P/S Is Still On The Mark Following 33% Share Price Bounce

Elliptic Laboratories ASA ( OB:ELABS ) shareholders would be excited to see that the share price has had a great month...
User avatar
Nouvelle analyse May 11

Laptop And Smartphone AI Sensors Will Shape Future Markets

Expansion in the laptop and smartphone markets, with multiple AI sensors, is driving significant revenue growth and increased market penetration.

Ventilation des recettes et des dépenses

Comment Elliptic Laboratories gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

OB:ELABS Recettes, dépenses et bénéfices (NOK Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
31 Dec 25101-14090
30 Sep 25141-520
30 Jun 25127-1320
31 Mar 25136020
31 Dec 24132920
30 Sep 2494-2220
30 Jun 2487-2520
31 Mar 2487-2620
31 Dec 2368-3820
30 Sep 2369-3710
30 Jun 2374-2310
31 Mar 2351-3410
31 Dec 2252-3310
30 Sep 2277-1010
30 Jun 2263-1810
31 Mar 2258-1710
31 Dec 2155-1110
30 Sep 2144-510
30 Jun 2134-910
31 Mar 2132-1010
31 Dec 2030-1310
30 Sep 2023-2410
30 Jun 2029-2010
31 Mar 2032-1910
31 Dec 1938-1310
31 Dec 1842-2820
31 Dec 1711-3430

Des revenus de qualité: ELABS n'est actuellement pas rentable.

Augmentation de la marge bénéficiaire: ELABS n'est actuellement pas rentable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: ELABS n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 26.9% par an.

Accélération de la croissance: Impossible de comparer la croissance des bénéfices de ELABS au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable

Bénéfices par rapport au secteur d'activité: ELABS n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Software ( 8.9% ).


Rendement des fonds propres

ROE élevé: ELABS a un retour sur capitaux propres négatif ( -74.45% ), car il n'est actuellement pas rentable.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/05/08 08:46
Cours de l'action en fin de journée2026/05/08 00:00
Les revenus2025/12/31
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Elliptic Laboratories ASA est couverte par 1 analystes. 1 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Jørgen WeidemannPareto Securities